Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial
2023 · Cardiovascular Diabetology · 134 citations
https://doi.org/10.1186/s12933-023-01765-z